CURE recently spoke with CEPHEUS study investigator Dr. Saad Z. Usmani, chief of the myeloma service at Memorial Sloan Kettering Cancer Center. Last week, the U.S. Food and Drug Administration (FDA) ...

Targeted therapies, bispecifics, and CAR T-cell therapies are giving patients with multiple myeloma hope for long-term remission or a potential cure. He expanded on this topic during the panel, ...

The second most common cancer in the hematologic (blood) cancer category is multiple myeloma. It accounts for about 13% of all cases of blood cancer. 63% of ...

"Multiple myeloma is a marathon, not a sprint," Annamarie emphasized in an interview with CURE. To avoid the exhaustion that ...

Multiple myeloma is a serious but often misunderstood disease. It affects thousands of people every year, including many in Black communities, where the risk is nearly twice as high as ...

Multiple myeloma is a cancer in which plasma cells, which normally produce antibodies, multiply uncontrollably in the bone marrow. There is currently no cure. However, various therapies can stabilize ...

(InvestigateTV) — Nearly 200,000 people in the United States live with multiple myeloma, a cancer that occurs when a type of white blood cell grows out of control, causing low blood counts, bone and ...

Over the years, Myeloma Action Month (MAM) has been dedicated to raising awareness and inspiring action within the myeloma community. It has grown to become a global effort, reaching over 60 million ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. I think in general future research should ...

In " Beyond Diagnosis: Multiple Myeloma," Cleveland Clinic hematologist Sandra Mazzoni, DO, and host John Mangels discuss how ...